Eron, J. J., Clotet, B., Durant, J., Katlama, C., Kumar, P., Lazzarin, A., . . . Hawkins, T. (2013). Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press.
Citación estilo ChicagoEron, Joseph J., et al. Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press, 2013.
Cita MLAEron, Joseph J., et al. Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study. Oxford University Press, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.